A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

Completed · Phase 2

Conditions studied: Asthma

In brief

This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma

Key facts

Study ID

NCT00150397

Run by

Pfizer

People needed

112

Starts

2005-03-01

Expected to finish

2005-11-01

Last updated by the study team

2012-06-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild to moderate persistent asthma (NAEPP/GINA Step 2-3)
• Reversibility to albuterol at least 12% and 200 mL

You may not qualify if…

• Any significant co-morbid disease, particularly cardiovascular
• Use of any maintenance therapy except short acting bronchodilators
• Smoking history > or = 10 years

Where it is running

• Pfizer Investigational Site — Encinitas, California, United States
• Pfizer Investigational Site — Riverside, California, United States
• Pfizer Investigational Site — DeLand, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Normal, Illinois, United States
• Pfizer Investigational Site — Madisonville, Kentucky, United States
• Pfizer Investigational Site — North Dartmouth, Massachusetts, United States
• Pfizer Investigational Site — Springfield, Massachusetts, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Skillman, New Jersey, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Lincoln, Rhode Island, United States
• Pfizer Investigational Site — Kingsport, Tennessee, United States
• Pfizer Investigational Site — Nashville, Tennessee, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Madison, Wisconsin, United States
• Pfizer Investigational Site — Barrio Aranjuez, Provincia de San José, Costa Rica
• Pfizer Investigational Site — San José, Provincia de San José, Costa Rica
• Pfizer Investigational Site — Mumbai, Maharashtra, India
• Pfizer Investigational Site — Chennai, Tamil Nadu, India
• Pfizer Investigational Site — Vellore, Tamil Nadu, India
• Pfizer Investigational Site — Noida, Uttar Pradesh, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.